![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 22, 12836-12845, Aug, 1990
RL Ball, KD Tanner and G Carpenter
Epidermal growth factor (EGF) treatment of A-431 cells potentiates up to
5-fold the intracellular cyclic AMP (cAMP) accumulation induced by
isoproterenol, cholera toxin, forskolin, or 3-isobutyl-1-methylxanthine
(IBMX). EGF potentiates cAMP accumulation in several epithelial cell lines
which overexpress the EGF receptor including A-431 cells, HSC-1 cells, and
MDA-468 cells, and in the A-431-29S clone which expresses a normal
complement of EGF receptors. Although EGF potentiates cAMP accumulation,
EGF by itself does not measurably alter the basal level of cAMP. EGF
rapidly enhances cAMP accumulation (within 1 to 3 min) in A-431 cells
treated with these cAMP-elevating agents. EGF potentiation of cAMP
accumulation does not reflect enhancement of beta-adrenergic receptor
activation and is not a consequence of intracellular cAMP elevation or the
concomitant activation of cAMP-dependent protein kinase. Since EGF
potentiates accumulation of both intracellular and extracellular cAMP in
isoproterenol-treated A-431 cells, EGF does not potentiate intracellular
cAMP accumulation by inhibition of cAMP export. EGF potentiation of cAMP
accumulation is pertussis toxin- insensitive and does not result from EGF
inhibition of cAMP degradation in A-431 cells. These results demonstrate
that EGF transmembrane signaling includes an interaction with a component
of the adenylate cyclase system and that this interaction stimulates cAMP
synthesis resulting in enhancement of cAMP accumulation.
Epidermal growth factor potentiates cyclic AMP accumulation in A-431 cells
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Matthay, H. G. Folkesson, and C. Clerici Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema Physiol Rev, July 1, 2002; 82(3): 569 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassort Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium Physiol Rev, April 1, 2001; 81(2): 767 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boussouar and M. Benahmed Epidermal Growth Factor Regulates Glucose Metabolism Through Lactate Dehydrogenase A Messenger Ribonucleic Acid Expression in Cultured Porcine Sertoli Cells Biol Reprod, October 1, 1999; 61(4): 1139 - 1145. [Abstract] [Full Text] |
||||
![]() |
M. L. G. Lamm, R. M. Rajagopalan-Gupta, and M. Hunzicker-Dunn Epidermal Growth Factor-Induced Heterologous Desensitization of the Luteinizing Hormone/Choriogonadotopin Receptor in a Cell-Free Membrane Preparation Is Associated with the Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor Endocrinology, January 1, 1999; 140(1): 29 - 36. [Abstract] [Full Text] |
||||
![]() |
M. Grau, M. Soley, and I. Ramirez Interaction between Adrenaline and Epidermal Growth Factor in the Control of Liver Glycogenolysis in Mouse Endocrinology, June 1, 1997; 138(6): 2601 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watabe, Y. Masuda, S. Nakajo, T. Yoshida, Y. Kuroiwa, and K. Nakaya The Cooperative Interaction of Two Different Signaling Pathways in Response to Bufalin Induces Apoptosis in Human Leukemia U937 Cells J. Biol. Chem., June 14, 1996; 271(24): 14067 - 14073. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Graves, K. E. Bornfeldt, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells J. Biol. Chem., January 5, 1996; 271(1): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |